Today, scientists are on the verge of developing a vaccine to fight the new and terrifying strain of the zombie virus.
And this could save the lives of millions of people.
The disease, which is sweeping the world, has killed millions of humans since the pandemic began in the United States in 2009.
Now, researchers are preparing to make an injection to the body, injecting a tiny droplet of a special vaccine into a person’s bloodstream to stop their virus from spreading.
The vaccine would work by preventing the virus from replicating in the body.
The scientists say the vaccine could prevent millions of infected people from contracting the new virus, which has infected at least 6.6 million people around the world.
But it’s not quite that simple.
Scientists are developing a virus-specific vaccine, known as a plasmid, that can be injected into the body to block its virus replication.
Plasmids are small, specialized proteins that can carry a gene for a particular virus.
This gene, called the virus, controls the process of replicating the virus.
The virus then lives inside a special protein that is inserted into the bloodstream.
The plasmids also carry a genetic tag that tells the virus where to live.
The tag tells the plasmoid where to infect the cells that will be infected with the virus and cause the virus to be transferred to other cells.
In order to make the vaccine, researchers have developed an injection that’s made with a special type of fluorescent protein.
Researchers have also developed a virus vaccine using different kinds of antibodies that bind to the tag in different combinations, such as blocking it or making it sticky.
It’s not clear yet if the vaccine would have a good safety record, since the tag is a protein that can only be made by a small number of people, but the research has shown it would work well.
The next step for the researchers is to see if they can isolate and produce a vaccine using a different type of antibody.
It will be a challenge to do this, because they are using the same type of antibodies as used in the flu vaccine, but different antibodies that are very specific.
The antibody has been used to prevent the virus in humans before, and that vaccine has also been tested successfully in a monkey model.
If they can produce a drug that works in the human body, it could be a real game changer for public health, says Robert Litt, an immunologist at the Johns Hopkins University School of Medicine.
The researchers say the vaccines would work within minutes of the injection.
It could take just minutes to make, and if you could make it for a very small number, you could potentially get it to people before the pandemics are over.
If the pandems continue to spread, the vaccine might not be effective enough to stop all the spread, but could protect against a certain subset of cases.
The goal of the vaccine is to protect against the virus before it spreads, but Litt says it’s a really hard problem.
For one thing, people don’t have an immune system like other species.
It might take decades for a person to develop a tolerance for a certain type of vaccine, which means they could still be infected and spread the disease.
Another problem with the vaccine will be that it could not be administered directly to people in a controlled environment.
If you inject it into the veins, it would be hard to see the tag, and you could get it stuck in the blood stream.
So the researchers say there is a good chance the vaccine wouldn’t work as well if administered to people with underlying health conditions, like heart disease or diabetes.
It would also be difficult to administer a vaccine in the home, because people have different immune systems.
But there’s a lot of other research that shows vaccines work well for a variety of diseases, says Dr. Michael Mather, an infectious disease physician at Johns Hopkins.
“The good news is that there is an active research community in the field working on vaccines,” he says.
“There is not a shortage of scientists who are doing work in the vaccine area, and they are continuing to improve and improve vaccines to the best of their abilities.”
In other words, the research is going well.
But Mather says it will take a while before we see an effective vaccine that works as well as the flu vaccines that have worked so well for so long.
He says the goal is to get vaccines into people as soon as possible, but also to be cautious about introducing them to people who may not have an immunity to the disease or have underlying conditions.
It may take several years before we can see a vaccine that’s effective in humans.
But the team has already shown that the vaccine works, and it’s likely to work in humans as well.
There’s no evidence that the vaccines will work against the very, very common type of flu, which can cause respiratory symptoms, fever and pneumonia.
But as the pandemaker progresses, the researchers are hoping to find a way to make a vaccine even more